The Neurology & CNS Division focuses on the development, manufacturing, and distribution of high-quality pharmaceutical products for the management of neurological and neuropathic disorders. Operating under GMP-certified manufacturing facilities and in compliance with DRAP regulations and the Drug Licensing Management (DML) Rules 2019, the division is committed to delivering safe, effective, and reliable therapeutic solutions.
The division's portfolio addresses a wide range of neurological conditions, including neuropathic pain, epilepsy, anxiety disorders, diabetic neuropathy, post-herpetic neuralgia, fibromyalgia, and other nerve-related disorders. Through continuous innovation, stringent quality standards, and patient-centered care, the division supports healthcare professionals in improving treatment outcomes and enhancing patients' quality of life.
Pregabalin is indicated for the management of neuropathic pain, diabetic peripheral neuropathy, post-herpetic neuralgia, fibromyalgia, and as an adjunctive therapy for certain seizure disorders. It helps reduce nerve-related pain, improve patient comfort, and support better overall neurological health.